Skin Cancer Clinical Trials
Skin cancer clinical trials are used to compare emerging, innovative treatments to the current standard of care. These trials offer a number of benefits, such as:
- The ability to access new, promising drugs long before they are available in other settings
- The ability to explore additional therapies when other treatments do not provide adequate benefits (as is often the case with late-stage cancers)
- The ability to contribute to new developments that will eventually benefit thousands of patients who have been diagnosed with skin cancer
At Moffitt Cancer Center, our skin cancer clinical trials have tested some of the most promising developments in treatment to date. For instance, we’ve tested several forms of immunotherapy, intralesional therapy and molecular targeted therapy. Additionally, we’re one of the only centers in the country that has the protocol to test T-cell therapies, which boost the body’s natural ability to fight cancer using its own immune system.
When you participate in a clinical trial at Moffitt, you can expect to have your progress monitored by a team of oncologists who specialize in skin cancer. This way, we can ensure that you’re receiving an ideal dose of the treatment and that any side effects are kept to a minimum.
Depending on the protocol of your specific trial, you may also be able to receive additional treatments here at Moffitt Cancer Center. We’ll make sure that you’re receiving the treatments that are most appropriate for your specific diagnosis, and you’ll be able to access all of your treatments in one convenient location.
For more information about the skin cancer clinical trials offered at Moffitt, call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form. No referral is required; our clinical trial navigators will help you determine whether you might benefit from a clinical trial, and will explain to you all of the requirements involved.